Table of contents
Volume 94, Issue 1
Published online 11 January 2006 (1-178)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letter to the Editor |
Book Review
Minireviews
Adrenomedullin and tumour angiogenesis FREE
L L Nikitenko, S B Fox, S Kehoe, M C P Rees and R Bicknell
Br J Cancer 94: 1-7; advance online publication, October 25, 2005; doi:10.1038/sj.bjc.6602832
The measurement and therapeutic implications of circulating tumour cells in breast cancer FREE
J B Smerage and D F Hayes
Br J Cancer 94: 8-12; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602871
A twist for survival and cancer progression FREE
A Puisieux, S Valsesia-Wittmann and S Ansieau
Br J Cancer 94: 13-17; advance online publication, November 22, 2005; doi:10.1038/sj.bjc.6602876
Clinical Studies
Time and chemotherapy treatment trends in the treatment of elderly patients (age 
70 years) with small cell lung cancer FREE
T Yau, S Ashley, S Popat, A Norton, A Matakidou, J Coward and M E R O'Brien
Br J Cancer 94: 18-21; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602888
Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980–1994 FREE
C A Stiller, S J Passmore, M E Kroll, P A Brownbill, J C Wallis and A W Craft
Br J Cancer 94: 22-29; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602885
Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom FREE
J E Lester, D Dodwell, J M Horsman, S Mori and R E Coleman
Br J Cancer 94: 30-35; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602892
Effects of specialisation on treatment and outcomes in screen-detected breast cancers in Wales: cohort study FREE
P C Allgood and M O Bachmann
Br J Cancer 94: 36-42; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602894
Factors associated with emotional and behavioural problems among school age children of breast cancer patients FREE
M Watson, I St. James-Roberts, S Ashley, C Tilney, B Brougham, L Edwards, C Baldus and G Romer
Br J Cancer 94: 43-50; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602887
Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate? FREE
T Powles, P Savage, D Short, A Young, C Pappin and M J Seckl
Br J Cancer 94: 51-54; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602899
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer FREE
A R Clamp, J Mäenpää, D Cruickshank, J Ledermann, P M Wilkinson, R Welch, S Chan, P Vasey, B Sorbe, A Hindley and G C Jayson for the Scottish Gynaecological Cancer Trials Group
Br J Cancer 94: 55-61; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602910
SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer FREE
P A Vasey, R Atkinson, R Osborne, D Parkin, R Symonds, J Paul, L Lewsley, R Coleman, N S Reed, S Kaye and G J S Rustin
Br J Cancer 94: 62-68; doi:10.1038/sj.bjc.6602909
'A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer' FREE
J Bennouna, H Perrier, B Paillot, F Priou, J H Jacob, M Hebbar, S Bordenave, J F Seitz, F Cvitkovic, E Dorval, K Malek, D Tonelli and J Y Douillard
Br J Cancer 94: 69-73; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602913
Combination chemotherapy with carboplatin, capecitabine and epirubicin (ECarboX) as second- or third-line treatment in patients with relapsed ovarian cancer: a phase I/II trial FREE
C Rothermundt, R Hubner, T Ahmad, I Gibbens, C Keyzor, T Habeshaw, S Kaye and M Gore
Br J Cancer 94: 74-78; advance online publication, November 22, 2005; doi:10.1038/sj.bjc.6602879
A phase I and pharmacokinetic study of novel taxane BMS-188797 and cisplatin in patients with advanced solid tumours FREE
A du Bois, B Jung, A Loehr, T Schaller-Kranz, M Cohen and N Frickhofen
Br J Cancer 94: 79-84; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602886
Translational Therapeutics
Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies FREE
I Laux, A Jain, S Singh and D B Agus
Br J Cancer 94: 85-92; advance online publication, November 22, 2005; doi:10.1038/sj.bjc.6602875
Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells FREE
J C Panetta, W E Evans and M H Cheok
Br J Cancer 94: 93-100; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602893
Macrophages promote angiogenesis in human breast tumour spheroids in vivo FREE
L Bingle, C E Lewis, K P Corke, M W R Reed and N J Brown
Br J Cancer 94: 101-107; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602901
Molecular Diagnostics
Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma FREE
D Xie, Y X Zeng, H J Wang, J M Wen, Y Tao, J S T Sham and X Y Guan
Br J Cancer 94: 108-114; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602904
No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix FREE
P Kabuubi, J A Loncaster, S E Davidson, R D Hunter, C Kobylecki, I J Stratford and C M L West
Br J Cancer 94: 115-120; advance online publication, November 29, 2005; doi:10.1038/sj.bjc.6602882
The effect of surgically induced ischaemia on gene expression in a colorectal cancer xenograft model FREE
G Atkin, F M Daley, S Bourne, R Glynne-Jones, J Northover and G D Wilson
Br J Cancer 94: 121-127; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602905
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers FREE
P Went, M Vasei, L Bubendorf, L Terracciano, L Tornillo, U Riede, J Kononen, R Simon, G Sauter and P A Baeuerle
Br J Cancer 94: 128-135; doi:10.1038/sj.bjc.6602924
Epidemiology
Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas FREE
M Lindblad, L A García Rodríguez, E Chandanos and J Lagergren
Br J Cancer 94: 136-141; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602906
Birth outcome in women with breast cancer FREE
V Langagergaard, M Gislum, M V Skriver, B Nørgård, T L Lash, K J Rothman and H T Sørensen
Br J Cancer 94: 142-146; advance online publication, November 22, 2005; doi:10.1038/sj.bjc.6602878
Role of mammography screening as a predictor of survival in postmenopausal breast cancer patients FREE
J Anttinen, H Kautiainen and T Kuopio
Br J Cancer 94: 147-151; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602895
Social inequalities in breast cancer mortality among French women: disappearing educational disparities from 1968 to 1996 FREE
G Menvielle, A Leclerc, J-F Chastang and D Luce for the EDISC group
Br J Cancer 94: 152-155; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602907
Adiponectin in relation to childhood myeloblastic leukaemia FREE
E Petridou, C S Mantzoros, N Dessypris, S K Dikalioti and D Trichopoulos the Childhood Hematology Oncology Group
Br J Cancer 94: 156-160; doi:10.1038/sj.bjc.6602896
Magnetic field exposure and long-term survival among children with leukaemia FREE
D E Foliart, B H Pollock, G Mezei, R Iriye, J M Silva, K L Ebi, L Kheifets, M P Link and R Kavet
Br J Cancer 94: 161-164; advance online publication, January 10, 2006; doi:10.1038/sj.bjc.6602916
Dairy consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer FREE
M Mommers, L J Schouten, R A Goldbohm and P A van den Brandt
Br J Cancer 94: 165-170; advance online publication, November 22, 2005; doi:10.1038/sj.bjc.6602890
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands FREE
S Bulk, J Berkhof, N W J Bulkmans, G D Zielinski, L Rozendaal, F J van Kemenade, P J F Snijders and C J L M Meijer
Br J Cancer 94: 171-175; advance online publication, December 13, 2005; doi:10.1038/sj.bjc.6602915
Letter to the Editor
Does a truncated form of the transcription factor Ets1 exist in breast cancer cells? FREE
J Dittmer
Br J Cancer 94: 176-177; advance online publication, December 6, 2005; doi:10.1038/sj.bjc.6602903
Book Review
Nerve Blocks in Palliative Care FREE
A P Baranowski
Br J Cancer 94: 178; doi:10.1038/sj.bjc.6602884
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
